DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
about
Cancer/Testis Antigen PASD1 Silences the Circadian ClockDNA vaccine for cancer immunotherapyT cell-based targeted immunotherapies for patients with multiple myeloma.Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapyPASD1 promotes STAT3 activity and tumor growth by inhibiting TC45-mediated dephosphorylation of STAT3 in the nucleus.Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination.
P2860
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@en
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@nl
type
label
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@en
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@nl
prefLabel
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@en
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@nl
P2093
P2860
P356
P1433
P1476
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
@en
P2093
D Joseph-Pietras
K Ait-Tahar
N Savelyeva
S S Sahota
P2860
P2888
P304
P356
10.1038/LEU.2010.196
P577
2010-09-23T00:00:00Z
P6179
1049284533